Found 310 matching trials
Human Upper Extremity Allotransplantation PHASE2 Background: Millions of people each year sustain injuries, have tumors surg...
Show More Location
Johns Hopkins University School of Medicine
Learn More & Join Trial
Atezolizumab and Chemotherapy Treatment as T-cell Activators in Metastatic Triple Negative Breast Cancer Patients PHASE2 Triple-negative breast cancer (TNBC) is among the most aggressive and letha...
Show More Location
Fondazione IRCCS San Gerardo Dei Tintori
Learn More & Join Trial
A Clinical Study of Sotatercept (MK-7962) in People With Pulmonary Arterial Hypertension (MK-7962-031/LIGHTRAY EXTENSION) PHASE2 Researchers are looking for other ways to treat pulmonary arterial hyperten...
Show More Status
Active Not Recruiting
Location
University of Colorado Anschutz Medical Campus-University of Colorado Hospital Cardiac and Vascular ( Site 1930)
Learn More & Join Trial
A Study of JS009 Monotherapy and JS009 as a Triple Combination Therapy in Patients With Advanced Malignancies PHASE1 The study is being conducted to evaluate the Safety, Tolerability, Pharmaco...
Show More Location
Multiple Locations
Learn More & Join Trial
Atezolizumab Combined With BDB001 AnD Immunogenic Radiotherapy in Patients With Advanced Solid Tumors PHASE2 Basket trial concept to independently and simultaneously assess the effects...
Show More Status
Active Not Recruiting
Location
Institut Bergonié
Learn More & Join Trial
Novel Triple-dose Tuberculosis Retreatment Regimen PHASE3 To determine if a high-dose first-line regimen is non-inferior (non-inferio...
Show More Location
Damien Foundation
Learn More & Join Trial
Genetically Engineered Cells (MAGE-A1-specific T Cell Receptor-transduced Autologous T-cells) and Atezolizumab for the Treatment of Metastatic Triple Negative Breast Cancer, Urothelial Cancer, or Non-small Cell Lung Cancer PHASE1 This phase I/II trial investigates the side effects of genetically engineer...
Show More Location
Fred Hutch/University of Washington Cancer Consortium
Learn More & Join Trial
Phase II Study Evaluating the Efficacy and Safety of Ociperlimab in Combination With Tislelizumab and Chemotherapy as First-line Treatment for Participants With Advanced Triple Negative Breast Cancer PHASE2 The primary scientific question of interest of this study is whether the co...
Show More Location
Multiple Locations
Learn More & Join Trial
Subcutaneous Epcoritamab With or Without Lenalidomide as First Line Therapy for Diffuse Large B-Cell Lymphoma PHASE2 The purpose of the study is to examine efficacy and safety of epcoritamab w...
Show More Location
UW Cancer Center at ProHealth Care
Learn More & Join Trial
Clinical Study to Evaluate Debio0123 + Sacituzumab Govitecan Combination in TNBC or HR+/HER2- Advanced Breast Cancer PHASE1 The WIN-B is an international, multicenter, single-arm, phase Ib/II study t...
Show More Status
Active Not Recruiting
Location
Hospital Universitari Dexeus
Learn More & Join Trial